DTx Pharma Completes $100M Series B Financing to Advance its FALCON™ Platform and Pipeline of RNA Therapeutics

2021-04-22T13:54:29-07:00March 1st, 2021|

Proceeds will enable further platform development and accelerate the path toward clinical development Matthew Hammond, Ph.D., Principal at RA Capital Management, and Dan Becker, [...]